Paediatric constipation: the two-phase management approach

Constipation is one of the most common reasons Australian families attend their GP with a child, accounting for around 3–5 per cent of paediatric outpatient consultations and up to 25 per cent of paediatric gastroenterology referrals. The vast majority — more than 90 per cent — is functional, with no underlying organic disease. Yet mismanagement is common: laxative doses too low, treatment stopped prematurely, and faecal soiling misunderstood as deliberate misbehaviour. This article sets out the evidence-based approach recommended by the Royal Children’s Hospital Melbourne and the Continence Foundation of Australia, and endorsed in Australian general practice literature.

A. Core clinical — the AU general-practice framework

Rome IV diagnostic criteria

The Rome IV criteria define functional constipation in children four years and older as two or more of the following six features, present for at least one month, with insufficient criteria for irritable bowel syndrome:

1. Two or fewer defaecations per week
2. At least one episode of faecal incontinence per week after toilet training has been achieved
3. A history of retentive posturing or excessive volitional stool retention
4. A history of painful or hard bowel motions
5. A large faecal mass palpable in the rectum on examination
6. A history of large-diameter stools that may obstruct the toilet

In children under four years (still in nappy or early toilet training), criterion 2 is adapted: at least one episode per month of passage of a large, difficult stool. The criteria establish a positive diagnosis but do not override clinical judgement — red flags always take priority, regardless of how “typical” the history sounds.

History

A structured history is the diagnostic cornerstone. Key elements include:

• Onset timing: constipation from birth or the first few weeks of life raises the possibility of Hirschsprung disease. Onset correlating with introduction of cow’s milk formula, starting solids, toilet training, or beginning school is typical for functional constipation.
• Stool consistency and frequency: using the Bristol Stool Scale standardises descriptions — types 1 and 2 are constipated; type 4 is ideal.
• Pain with defaecation: even a single episode of painful defaecation can initiate a fear-avoidance withholding cycle that perpetuates itself.
• Soiling: establish frequency, quantity, and whether the child perceives the urge before soiling. Involuntary soiling without warning almost always indicates overflow from faecal impaction.
• Dietary intake: estimated fluid and fibre intake. Cow’s milk intake >500 mL/day is a common contributor — it displaces fibre-rich foods, and cow’s milk protein may directly impair colonic motility in susceptible children.
• Toilet habits: avoidance of school toilets is extremely common and frequently drives daytime withholding — address this directly.
• Medications: iron supplementation, opioids, anticholinergics, ondansetron, and aluminium-containing antacids can all cause constipation.
• Family history: Hirschsprung disease, coeliac disease, hypothyroidism, or inflammatory bowel disease in first-degree relatives raises pre-test probability of organic disease.

Red flags requiring investigation or specialist review

The RCH Melbourne Clinical Practice Guidelines identify the following features as inconsistent with functional constipation:

• Passage of first meconium delayed beyond 48 hours of birth (Hirschsprung disease until proved otherwise)
• Constipation presenting in the first month of life
• Failure to thrive or poor linear growth (coeliac disease, hypothyroidism, systemic illness)
• Abdominal distension with bilious vomiting
• Sacral dimple below the gluteal crease, hairy patch overlying the sacrum, or gluteal cleft asymmetry (spinal cord anomaly — tethered cord, occult spina bifida)
• Abnormal lower limb tone, power, or deep tendon reflexes
• Bloody diarrhoea during or after constipation treatment — this may represent Hirschsprung-associated enterocolitis, which is a surgical emergency
• Constipation with perianal fistula, skin tags, or eccentric fissures (Crohn disease)

Physical examination

Growth parameters (height, weight, BMI percentile) are mandatory — poor growth is a red flag for organic disease. Abdominal palpation should assess for a palpable faecal mass in the left iliac fossa or suprapubic region. Inspection of the lumbosacral region, perineum, and anus is important: note the position of the anus, anal tone at rest, any skin tags, fissures, or excoriation. A digital rectal examination is not routinely required in general practice — it is distressing for children (particularly those with painful defaecation) and rarely changes initial management.

Investigations

No investigations are needed for straightforward functional constipation. Plain abdominal X-ray is not recommended — it correlates poorly with clinical findings, exposes the child to ionising radiation, and does not reliably guide management decisions. Blood tests (thyroid function, coeliac antibodies, calcium, full blood examination, ferritin) are appropriate only when red flag features are present or when the response to adequate treatment is poor. Rectal suction biopsy to exclude aganglionosis is a specialist investigation, not a general practice test.

---

B. Two-phase management — disimpaction then maintenance

Phase 1: Disimpaction

When faecal impaction is present — either palpable abdominally or strongly suggested by history (large, infrequent, painful stools; overflow soiling) — disimpaction must precede maintenance therapy. Starting maintenance doses without clearing an impaction produces weeks of poor response and erodes family confidence in the treatment plan.

The first-line agent is polyethylene glycol 3350 (Movicol Paediatric Plain) per eTG Complete. The disimpaction dose is 1–1.5 g/kg/day in divided doses over three to seven days. For an 18 kg child, this equates to approximately 18–27 g/day — roughly two to four sachets of Movicol Paediatric Plain daily. Titrate upward until stools become watery or very loose, which confirms successful disimpaction. Temporary watery stools at this stage are therapeutic, not an adverse effect requiring dose reduction.

If oral disimpaction fails after adequate doses for five to seven days, refer for paediatric assessment. Manual disimpaction under procedural sedation, or adjunct bisacodyl or sodium picosulfate suppositories, may be required. Phosphate enemas are not used routinely in Australian paediatric practice because of the risk of hyperphosphataemia in young children.

Phase 2: Maintenance therapy

Following disimpaction, reduce to maintenance dosing: PEG 0.4–0.8 g/kg/day, aiming for one soft, comfortable stool daily. For an 18 kg child, this is approximately 7–14 g/day (roughly one to two sachets). Adjust fortnightly based on stool consistency and frequency.

The NASPGHAN/ESPGHAN guidelines and RCH Melbourne both emphasise that maintenance must continue for a minimum of six to twelve months, often longer. Premature cessation — the most common management error in Australian general practice — leads predictably to re-impaction. Families need to hear explicitly: “We are not stopping the medication once the soiling stops. We keep going until the bowel has fully recovered, which takes months.”

Lactulose (1–2 mL/kg/day in divided doses) is an acceptable alternative if PEG is declined or poorly tolerated. Stimulant laxatives (bisacodyl, sodium picosulfate) serve as short-term adjuncts when stool frequency remains inadequate on osmotic agents alone.

Behavioural toilet training (children ≥3 years)

Laxative therapy alone is rarely sufficient. A structured behavioural programme substantially improves outcomes when added to medication. Key components:

• Regular sit time after meals: exploiting the gastrocolic reflex — five to ten minutes on the toilet after each main meal, at least twice daily.
• Correct posture: feet flat on a footstool so the knees are above the hips, which optimises the anorectal angle and reduces straining effort.
• Positive reinforcement: reward sitting — not just successful defaecation — using sticker charts, praise, or small rewards. Sitting is the behaviour within the child’s control; passing a stool is not always.
• Never punish soiling: punishment of involuntary overflow incontinence causes shame, entrenches avoidance, and destroys the therapeutic relationship between the child and carers.
• Explain the timeline: families need a realistic timeframe — measured in months, not weeks. A single clinic consultation rarely resets years of fear-avoidance; consistent follow-up appointments (two to four weekly initially) maintain momentum.

---

C. Encopresis, the parent–child dynamic, and psychosocial impact

Encopresis — faecal soiling in a toilet-trained child — is present in up to 30 per cent of children with chronic functional constipation. It results from chronic rectal distension impairing the child’s ability to sense the urge to defaecate, allowing liquid stool to leak around a retained faecal mass. Families almost universally misinterpret this as wilful, passive-aggressive, or attention-seeking behaviour, and the resulting conflict delays treatment and compounds the child’s shame.

The GP’s most powerful intervention may be naming this dynamic explicitly: “Your child physically cannot feel when stool is coming. The rectum is so stretched that the sensation is lost. This is a body problem, not a behaviour problem. Punishing or shaming will not help and is likely making things worse.” Delivering this framing clearly, without judgment, and with written reinforcement (the RCH parent handout is excellent) substantially improves family cooperation with treatment.

Children with encopresis face significant social consequences: bullying, school avoidance, peer withdrawal, and secondary anxiety or depression. When these are prominent, or when family relationships have deteriorated around toileting conflicts, referral to a paediatric psychologist or Continence Foundation of Australia continence nurse specialist is appropriate alongside — not instead of — continued medical management.

Higher rates of constipation and encopresis are documented in children with autism spectrum disorder, ADHD, cerebral palsy, and anxiety. Sensory sensitivities around the toilet (texture, sound, smell), rigidity around routine, and heightened pain perception complicate management. Adjust the toilet environment (insert seat, footstool, noise reduction), extend the maintenance timeline expectations, and involve allied health early.

---

D. Australian operations

Prescribing and PBS access

Movicol Paediatric Plain (PEG 3350 with electrolytes, 6.9 g per sachet) is PBS-listed and available on prescription in Australia. It is the standard agent for both disimpaction and maintenance in Australian paediatric practice per eTG Complete. Lactulose is also PBS-listed as an alternative.

The RCH Melbourne CPG as a clinical anchor

The RCH Melbourne Paediatric Constipation Clinical Practice Guideline provides dose tables, decision flowcharts, and free parent information sheets in accessible language. Printing or emailing the parent handout at the first consultation is standard practice — it reinforces the key messages (months not weeks, soiling is involuntary) and reduces premature medication cessation.

When to refer

• Paediatric gastroenterology: inadequate response after three to six months of adequate maintenance PEG at recommended doses; red flag features; severe encopresis with significant psychosocial impact.
• Paediatric surgery or colorectal: suspected Hirschsprung disease (delayed meconium, neonatal onset, failure to thrive, persistent distension) — refer urgently or semi-urgently depending on clinical picture.
• Continence nurse specialist: available through some children’s hospitals and community health centres — valuable for families needing behavioural coaching and ongoing toilet-training support.
• Paediatric psychologist: prominent school avoidance, family conflict, secondary anxiety or depression, or neurodevelopmental comorbidities complicating management.

ATSI children

The Raising Children Network provides culturally accessible information on constipation. Use accredited interpreter services where English is not the primary home language. Management principles are identical; acknowledge potential barriers such as limited access to high-fibre foods in some remote communities and build the plan accordingly. ACCHOs with paediatric nursing support can provide excellent ongoing follow-up.

---

E. Special populations

Infants under six months

Rome IV criteria do not apply in the same way to young infants. Exclusively breastfed infants commonly pass stools as infrequently as once per week after the first few weeks of life — if they are thriving, comfortable, and stools are soft, this is normal. The key marker is comfort and stool consistency, not frequency. Reassure without treatment. Glycerine suppositories can provide short-term relief if an infant is clearly distressed. Formula-fed infants typically stool more frequently; significant infrequency in a formula-fed infant warrants review of technique (overconcentration) and formula type.

Cow’s milk protein involvement

In infants and toddlers with constipation resistant to standard management, a two to four week elimination of cow’s milk protein is reasonable before escalating therapy. In breastfed infants, this means maternal elimination of dairy; in formula-fed infants, a trial of extensively hydrolysed or amino acid-based formula; in older toddlers, a dairy-free diet. Improvement within two weeks suggests cow’s milk protein as a contributor.

Neurodevelopmental conditions

Children with autism spectrum disorder, ADHD, and cerebral palsy have higher rates of functional constipation driven by sensory sensitivities, dietary restriction, reduced physical activity, and medications (methylphenidate, risperidone). Management principles are identical, but the behavioural component requires adaption to the child’s cognitive level and sensory profile, and maintenance therapy typically needs to continue longer.

Adolescents

Reassess the diagnosis in an adolescent with new or changing bowel habits. Consider: inflammatory bowel disease (particularly Crohn disease — abdominal pain, perianal disease, growth concerns); eating disorders (restriction, laxative misuse, caloric restriction); coeliac disease; hypothyroidism; and in girls, endometriosis (cyclical bowel symptoms). Arrange coeliac serology, thyroid function, and faecal calprotectin before assuming functional aetiology if the presentation is atypical.

---

When to escalate

Urgent (same day to 24 hours):

• Abdominal distension with bilious vomiting
• Bloody diarrhoea occurring during constipation treatment (possible Hirschsprung-associated enterocolitis)
• Severe neurological lower limb signs with sacral anomaly

Semi-urgent (within one to two weeks):

• Constipation from birth or the first month of life
• Delayed passage of first meconium beyond 48 hours
• Failure to thrive or poor linear growth
• Suspected coeliac disease or hypothyroidism — arrange bloods and refer

Routine paediatric gastroenterology referral:

• Inadequate response after three to six months of adequate maintenance PEG at recommended doses
• Severe persistent encopresis causing significant psychosocial impact
• Diagnostic uncertainty requiring specialist assessment

---

What this article is and is not

This article is a clinical education summary for Australian GPs, written to reflect current evidence-based guidelines including the RCH Melbourne Clinical Practice Guidelines, NASPGHAN/ESPGHAN recommendations, and eTG Complete. It is not a substitute for direct clinical assessment of individual patients. Children with red flag features, organic pathology, or complex neurodevelopmental needs require specialist involvement. AHPRA standards require that treatment decisions are made by qualified practitioners based on each patient’s individual circumstances.

---

Sources cited

See frontmatter sources array for the full citation list with evidence tiers.